Showing 1 - 6 results of 6 for search 'Shaozhang Zhou', query time: 0.03s Refine Results
  1. 1
    Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

    Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy by Shubin Chen, Qitao Yu, Shaozhang Zhou

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Correlation between KRAS mutation subtypes and prognosis in Chinese advanced non‐squamous non‐small cell lung cancer patients

    Correlation between KRAS mutation subtypes and prognosis in Chinese advanced non‐squamous non‐small cell lung cancer patients by Feiwen Liu, Fang Wang, Jianbo He, Shaozhang Zhou, Min Luo

    Published 2023-06-01
    Get full text
    Article
  3. 3
    The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials

    The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic revi... by Shubin Chen, Wanying Mo, Wei Jiang, Shaozhang Zhou, Haijie Gan, Qitao Yu

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Pretreatment plasma -dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer

    Pretreatment plasma -dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer by Qianfei Liu, Jianbo He, Ruiling Ning, Liping Tan, Aiping Zeng, Shaozhang Zhou

    Published 2020-10-01
    Get full text
    Article
  5. 5
    The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis

    The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score... by Huiqin Jiang*, Wei Jiang*, Liping Tan, Qitao Yu, Feiwen Liu, Yucong Huang, Jianbo He, Shaozhang Zhou

    Published 2021-04-01
    Get full text
    Article
  6. 6
    PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study

    PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with ad... by Shubin Chen, Haowen Wei, Wenhua Zhao, Wei Jiang, Ruiling Ning, Shaozhang Zhou, Liping Tan, Huilin Wang, Cuiyun Su, Jianbo He, Aiping Zeng, Yun Zhao, Yun Zhao, Qitao Yu

    Published 2022-12-01
    Get full text
    Article

Search Tools: